Published in Circulation on March 01, 1991
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ (1995) 6.28
Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart (1996) 3.85
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study. J Epidemiol Community Health (2001) 2.07
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg (2011) 1.76
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood (2011) 1.73
Air pollution and mortality in Barcelona. J Epidemiol Community Health (1996) 1.57
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study. Br Heart J (1993) 1.52
Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart (2001) 1.49
Occupational exposure to dust: inflammation and ischaemic heart disease. Occup Environ Med (1997) 1.39
Health status as a potential effect modifier of the relation between noise annoyance and incidence of ischaemic heart disease. Occup Environ Med (2003) 1.31
Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort. J Epidemiol Community Health (1999) 1.30
Measurement of magnetic nanoparticle relaxation time. Med Phys (2012) 1.27
Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg (2011) 1.17
Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart (1996) 1.17
The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol (2013) 1.10
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J (1993) 1.09
Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood (2012) 1.08
What determines mortality risk in male former cigarette smokers? Am J Public Health (1994) 1.07
Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol (2008) 1.03
Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J (1994) 1.03
Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women. Int J Biometeorol (2008) 1.01
Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry (1998) 0.99
Fibrinogen. BMJ (1991) 0.95
Blood pressure reactions to the cold pressor test and the prediction of ischaemic heart disease: data from the Caerphilly Study. J Epidemiol Community Health (1998) 0.93
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease. BMC Neurol (2007) 0.93
The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. J Thorac Dis (2013) 0.91
Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. Vasc Health Risk Manag (2008) 0.91
Lung injury after cigarette smoking is particle related. Int J Chron Obstruct Pulmon Dis (2011) 0.91
Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol (2007) 0.90
Homocysteine and ischaemic stroke in men: the Caerphilly study. J Epidemiol Community Health (2001) 0.89
Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic Microscopy. PLoS One (2015) 0.88
Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J (1994) 0.87
Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health (2002) 0.86
Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes. Cardiovasc Diabetol (2013) 0.85
The clinical significance of whole blood viscosity in (cardio)vascular medicine. Neth Heart J (2002) 0.85
Ischaemic heart disease: association with haematocrit in the British Regional Heart Study. J Epidemiol Community Health (1994) 0.85
Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies. Am J Epidemiol (2012) 0.83
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review. Int J Nanomedicine (2006) 0.82
Association between job characteristics and plasma fibrinogen in a normal working population: a cross sectional analysis in referents of the SHEEP Study. Stockholm Heart Epidemiology Program. J Epidemiol Community Health (1999) 0.82
Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes. BMC Med Genet (2004) 0.81
Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin. Inflammation (2001) 0.81
Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Heart (1999) 0.81
Hemostatic risk factors for coronary heart disease. Circulation (1991) 0.81
Fibrinogen and cardiovascular disease. J Clin Pathol (1997) 0.80
Two urinary peptides associated closely with type 2 diabetes mellitus. PLoS One (2015) 0.80
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. Br J Clin Pharmacol (1995) 0.79
Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis. Pediatr Blood Cancer (2010) 0.78
Thickness dependent effective viscosity of a polymer solution near an interface probed by a quartz crystal microbalance with dissipation method. Sci Rep (2015) 0.78
Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. BMC Womens Health (2015) 0.78
Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis. Shock (2014) 0.78
Effects of smoking on healthy young men's hematologic parameters. North Clin Istanb (2014) 0.77
Control of fibrinogen biosynthesis: role of the FFA/albumin ratio. Cardiovasc Eng (2010) 0.77
The role of hemorheological factors in cardiovascular medicine. Clin Hemorheol Microcirc (2014) 0.77
Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes (2011) 0.77
Expanded network of inflammatory markers of atherogenesis: where are we now? Open Cardiovasc Med J (2010) 0.77
Blood viscometer applying electromagnetically spinning method. J Artif Organs (2013) 0.76
Does weight loss reduce plasma fibrinogen? Br Heart J (1993) 0.76
Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort. Heart (1998) 0.76
Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefes Arch Clin Exp Ophthalmol (1996) 0.76
Iron and coronary heart disease. Control for haematological variables. BMJ (1993) 0.75
Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors. Circulation (1992) 0.75
Fibrinogen, viscosity, and white blood cell count. Circulation (1992) 0.75
Recent advances in ischaemic heart disease. Postgrad Med J (2000) 0.75
rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients. ScientificWorldJournal (2013) 0.75
Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study. Thromb J (2017) 0.75
Sonic Estimation of Elasticity via Resonance: A New Method of Assessing Hemostasis. Ann Biomed Eng (2015) 0.75
Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran. ARYA Atheroscler (2014) 0.75
Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia. Br J Clin Pharmacol (1998) 0.75
Effort-Reward Imbalance at Work and Incident Coronary Heart Disease: A Multicohort Study of 90,164 Individuals. Epidemiology (2017) 0.75
Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? Trans Am Clin Climatol Assoc (1996) 0.75
No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis. J Clin Pathol (2006) 0.75
Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity. J Diabetes Res (2016) 0.75
Cohort study of the total leukocyte count and periodontal disease among company employees. Environ Health Prev Med (1999) 0.75
Biochemical biomarkers are not dependent on physical exercise in patients with spinal cord injury. BBA Clin (2016) 0.75
Hypercoagulability in dogs with blastomycosis. J Vet Intern Med (2015) 0.75
Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk. Arterioscler Thromb Vasc Biol (2016) 0.75
Effort-reward imbalance at work and incident coronary heart disease: a multi-cohort study of 90,164 individuals. Epidemiology (2017) 0.75
Comparison of viscoelastic properties of cancer and normal thyroid cells on different stiffness substrates. Eur Biophys J (2016) 0.75
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet (1989) 9.27
General practitioners' opinions of health services available to their patients. BMJ (1991) 6.56
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Effects of salicylates on human platelets. Lancet (1968) 4.59
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J (1974) 3.80
Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr (2003) 3.38
Long term follow up of women after hysterectomy with a history of pre-invasive cancer of the cervix. Br J Obstet Gynaecol (1992) 2.72
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci U S A (1991) 2.67
Outbreak of giardiasis associated with mains water in the United Kingdom. Lancet (1986) 2.65
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J (2000) 2.59
The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction. Thromb Diath Haemorrh (1966) 2.50
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45
Treatment of acquired aphasia: speech therapists and volunteers compared. J Neurol Neurosurg Psychiatry (1982) 2.43
Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci (1972) 2.41
The Bristol shared care glaucoma study: outcome at follow up at 2 years. Br J Ophthalmol (2000) 2.38
Symptoms of iron deficiency anaemia. A community survey. Br J Prev Soc Med (1966) 2.35
The Bristol Shared Care Glaucoma Study--validity of measurements and patient satisfaction. J Public Health Med (1997) 2.21
Controlled trial of a home-care service for acute stroke patients. Lancet (1985) 2.19
Further follow-up study of workers from an asbestos cement factory. Br J Ind Med (1982) 2.18
Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr (1997) 2.14
Aspirin and secondary mortality after myocardial infarction. Lancet (1980) 2.12
Gallbladder disease. Prevalence in a South Wales industrial town. N Engl J Med (1976) 2.12
A short dietary questionnaire for use in an epidemiological survey: comparison with weighed dietary records. Hum Nutr Appl Nutr (1983) 2.10
Effects of exposure to slate dust in North Wales. Br J Ind Med (1980) 2.09
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Effect of anti-inflammatory agents on platelets. Lancet (1968) 1.95
Association between circulating haemoglobin level, serum-cholesterol, and blood-pressure. Lancet (1970) 1.94
Symptoms and circulating haemoglobin level. J Chronic Dis (1969) 1.93
Family size and paternal unemployment in relation to myocardial infarction. J Epidemiol Community Health (1980) 1.93
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Treatment of Infective Hepatitis with Methionine. Br Med J (1945) 1.79
What level of physical activity protects against premature cardiovascular death? The Caerphilly study. Heart (2003) 1.79
Guidelines for reading case-control studies. J Chronic Dis (1987) 1.78
Platelet function studies before and after operation and the effect of postoperative thrombosis. J Lab Clin Med (1974) 1.74
Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies. Eur Heart J (1992) 1.65
Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J (2004) 1.62
Temperature and deaths from ischaemic heart disease. Br J Prev Soc Med (1977) 1.62
Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening. Br Med J (1972) 1.61
Antibodies against lysosomal membranes reveal a 100,000-mol-wt protein that cross-reacts with purified H+,K+ ATPase from gastric mucosa. J Cell Biol (1984) 1.59
Vegetarianism, dietary fiber, and mortality. Am J Clin Nutr (1982) 1.59
Mortality in two radom samples of women aged 55-64 followed up for 20 years. Br Med J (1980) 1.57
Homocysteine and ischaemic heart disease in the Caerphilly cohort. Atherosclerosis (1998) 1.56
Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56
A survey of dust concentrations in flax mills in Northern Ireland. Br J Ind Med (1965) 1.54
Platelet function in venous thrombosis and low-dosage heparin. Lancet (1972) 1.53
Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. Eur Heart J (1996) 1.53
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study. Br Heart J (1993) 1.52
Blood and water lead in a hard water area. Lancet (1981) 1.52
Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem (1985) 1.50
Relationship of blood lead in women and children to domestic water lead. Nature (1979) 1.49
Refractory state of platelet aggregation with major operations. Lancet (1971) 1.48
Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study. J Epidemiol Community Health (2000) 1.47
Mortality and the concentration of elements in tap water in county boroughs in England and Wales. Br J Prev Soc Med (1977) 1.46
Changes in blood lead concentrations in women in Wales 1972-82. Br Med J (Clin Res Ed) (1983) 1.45
Immunity of children to diphtheria, tetanus, and poliomyelitis. Br Med J (1979) 1.44
The endothelial von Willebrand factor in venous occlusion blood. Thromb Haemost (1997) 1.43
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
"Rebleeding" the reversal of shear stress activation of platelets--a possible clue to thrombogenesis. Thromb Res (1992) 1.41
Prevalence of byssinosis and dust levels in flax preparers in Northern Ireland. Br J Ind Med (1966) 1.40
Blood lead and platelet aggregation--evidence for a causal association. Thromb Haemost (1991) 1.39
Early use of aspirin. Lancet (1990) 1.38
Puerperal thromboembolism and aspirin ingestion. Lancet (1970) 1.38
Progress report on an evaluation of speech therapy for aphasia. Br J Disord Commun (1979) 1.36
Haemoglobin estimation: a comparison of different techniques. Br Med J (1966) 1.35
Effect of oral iron therapy on the symptoms of anaemia. Br J Prev Soc Med (1966) 1.33
Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med (1989) 1.33
Drug prescribing by GPs in Wales and in England. J Epidemiol Community Health (1980) 1.31
Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys. J Clin Pathol (1987) 1.31
Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J (1982) 1.31
Respiratory disability in ex-cotton workers. Br J Ind Med (1986) 1.31
Mortality of flax workers. Br J Ind Med (1982) 1.30
Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax (2000) 1.29
Clinical significance of dysuria in women. Br Med J (1970) 1.29
Prevalence of ischaemic heart disease: the Caerphilly and Speedwell surveys. Br Heart J (1988) 1.28